News | April 17, 2025
Sigachi receives environmental clearance for greenfield Dahej manufacturing facility
The plant will have installed production capacity of 3,120 MT/month
The plant will have installed production capacity of 3,120 MT/month
The products will be manufactured in Goa India and marketed & distributed in Australian markets
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
the inspection conducted from January 27 to January 31, 2025
The facility is equipped with state-of-the-art technology to produce high-quality lyophilized (freeze-dried) products
Cenexi is committed to working closely with the ANSM to address the observations
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
First GMP batch released at Lonza’s next-generation mammalian manufacturing facility in Portsmouth (US)
This agreement reinforces Lubrizol’s commitment to Make-In-India and broadens a previously committed US$ 350 million investment to support local manufacturing
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
